SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000891293-19-000028
Filing Date
2019-04-04
Accepted
2019-04-04 08:30:17
Documents
5
Period of Report
2019-04-04
Effectiveness Date
2019-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A ctic-2019proxystatement.htm DEF 14A 722997
2 acraignsignaturea02.jpg GRAPHIC 8270
3 proxycard1a01.jpg GRAPHIC 24777
4 proxycard3a01.jpg GRAPHIC 121661
5 proxycard.jpg GRAPHIC 190746
  Complete submission text file 0000891293-19-000028.txt   1189509
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-28386 | Film No.: 19731235
SIC: 2834 Pharmaceutical Preparations